BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer.
ABBV-744
ARV-825
BRD4
c-Myc
p53
senescence
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 Aug 2023
11 Aug 2023
Historique:
received:
29
06
2023
revised:
03
08
2023
accepted:
07
08
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Breast cancer is the most commonly occurring malignancy in women and the second most common cause of cancer-related deaths. ER
Identifiants
pubmed: 37627092
pii: cancers15164066
doi: 10.3390/cancers15164066
pmc: PMC10452571
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA260819
Pays : United States
Références
Cancer Detect Prev. 2002;26(5):370-5
pubmed: 12518867
Int J Clin Oncol. 2019 Mar;24(3):262-273
pubmed: 30392115
Int J Mol Sci. 2022 Dec 02;23(23):
pubmed: 36499487
Curr Mol Med. 2013 Sep;13(8):1229-40
pubmed: 23865427
Br J Cancer. 2022 Jun;126(10):1363-1365
pubmed: 35304605
Mol Oncol. 2020 Oct;14(10):2504-2519
pubmed: 32652830
J Exp Clin Cancer Res. 2021 May 19;40(1):174
pubmed: 34011395
Cancer Biol Ther. 2014 Aug;15(8):1000-12
pubmed: 24801380
Cells. 2020 Feb 03;9(2):
pubmed: 32028565
Lancet Oncol. 2022 Mar;23(3):382-392
pubmed: 35123662
Int J Cancer. 2011 Apr 15;128(8):1813-21
pubmed: 20549698
Cancer Med. 2013 Dec;2(6):826-35
pubmed: 24403256
Mol Cells. 2019 Dec 31;42(12):821-827
pubmed: 31838837
Breast Cancer Res Treat. 2019 Jul;176(2):429-434
pubmed: 30895534
Ann Oncol. 2015 Aug;26(8):1533-46
pubmed: 25939896
Am J Transl Res. 2019 Sep 15;11(9):5728-5739
pubmed: 31632543
Biochem Pharmacol. 2008 Oct 15;76(8):947-57
pubmed: 18657518
J Natl Cancer Inst. 2015 Mar 30;107(6):djv048
pubmed: 25825511
Nat Genet. 2015 Jan;47(1):8-12
pubmed: 25547603
Breast Care (Basel). 2020 Aug;15(4):347-354
pubmed: 32982644
Oncol Rep. 2018 Mar;39(3):901-911
pubmed: 29399694
Lancet. 2015 Oct 3;386(10001):1341-1352
pubmed: 26211827
Clin Cancer Res. 2000 Nov;6(11):4373-80
pubmed: 11106256
Cancers (Basel). 2021 Feb 10;13(4):
pubmed: 33578753
Clin Cancer Res. 1995 Oct;1(10):1203-8
pubmed: 9815913
Life Sci. 2014 Mar 3;97(2):116-22
pubmed: 24361399
Cell Res. 2014 Jul;24(7):809-19
pubmed: 24874954
Cancers (Basel). 2011 Mar 03;3(1):994-1013
pubmed: 24212651
Cancer Res. 2009 Apr 15;69(8):3405-14
pubmed: 19351845
J Hematol Oncol. 2019 Jul 16;12(1):77
pubmed: 31311566
Mol Cancer. 2022 Aug 30;21(1):171
pubmed: 36042494
Br J Cancer. 1995 Nov;72(5):1259-66
pubmed: 7577479
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18060-5
pubmed: 23077249
Front Oncol. 2021 Oct 18;11:753119
pubmed: 34733788
Cancer Cell. 2020 Apr 13;37(4):496-513
pubmed: 32289273
Breast Cancer Res Treat. 2020 Nov;184(1):23-35
pubmed: 32783178
Front Oncol. 2020 Nov 26;10:574525
pubmed: 33324552
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Front Oncol. 2023 Jan 18;12:966441
pubmed: 36741704
Mol Cancer Ther. 2021 Oct;20(10):1809-1819
pubmed: 34253595
Cancer Cell Int. 2021 Apr 22;21(1):230
pubmed: 33888130
Cancer Res. 2000 Apr 15;60(8):2155-62
pubmed: 10786679
Drugs Context. 2019 Jul 16;8:212579
pubmed: 31391852
Br J Cancer. 2009 Nov 3;101(9):1606-12
pubmed: 19773755
Nature. 2020 Feb;578(7794):306-310
pubmed: 31969702
Mol Cell. 2018 Aug 16;71(4):592-605.e4
pubmed: 30057199
Autophagy. 2014;10(12):2346-61
pubmed: 25629933
Breast Cancer Res Treat. 2019 Apr;174(3):719-729
pubmed: 30632023
Mol Cell. 2013 Mar 7;49(5):843-57
pubmed: 23317504
Trends Mol Med. 2018 Oct;24(10):871-885
pubmed: 30153969
Biomed Rep. 2016 Jan;4(1):102-106
pubmed: 26870344
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15081-6
pubmed: 20696891
Cell Res. 2014 Aug;24(8):899-900
pubmed: 25001387
Nat Med. 1995 Oct;1(10):1029-34
pubmed: 7489358
Clin Cancer Res. 1996 Sep;2(9):1439-44
pubmed: 9816318
Cancers (Basel). 2022 Sep 01;14(17):
pubmed: 36077830
Target Oncol. 2019 Feb;14(1):1-12
pubmed: 30136059
Clin Breast Cancer. 2005 Apr;6 Suppl 1:S5-8
pubmed: 15865849
Mol Pharmacol. 2022 Mar;101(3):168-180
pubmed: 34907000
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
Front Pharmacol. 2021 Jan 26;11:621093
pubmed: 33574760
Cancer Drug Resist. 2022 Jun 01;5(2):472-486
pubmed: 35800378
Mol Cancer. 2018 Nov 22;17(1):164
pubmed: 30466442